SILVER SPRING, Md. — A novel injection drug aimed at eosinophilic asthma is safe and effective for adults, an FDA advisory committee decided Thursday, but the panel did not support approving the drug for adolescents. Members of the Pulmonary-Allergy Drugs Advisory Committee voted 14-0 that the overall data supported approval in adults 18 and older.

READ FULL ARTICLE Curated publisher From Medical Page Today